<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00669396</url>
  </required_header>
  <id_info>
    <org_study_id>23111</org_study_id>
    <secondary_id>IUDvsPlanBforEC</secondary_id>
    <nct_id>NCT00669396</nct_id>
  </id_info>
  <brief_title>Copper T380 IUD Versus Oral Levonorgestrel for Emergency Contraception vs. Plan B for Emergency Contraception</brief_title>
  <official_title>A Pilot Study of Copper T380A IUDs Versus Oral Levonorgestrel for Emergency Contraception</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Utah</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Utah</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to see if women presenting for emergency contraception (EC) are
      willing to accept the copper intrauterine device (IUD). This study will also compare the use
      of effective methods of contraception between women who selected the copper IUD or Plan B 6
      months after they received EC.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study seeks to estimate the acceptance of Copper IUD use amongst people presenting for
      EC. This will be accomplished by offering all women who present for EC at participating
      Planned Parenthood Association of Utah (PPAU) clinics during the study period the option of
      having the copper IUD or Plan B. Women who agree to study participation will be followed for
      6 months. The primary outcome for the study is the use of a reliable method of contraception
      6 months after presenting for EC.

      Secondary outcomes measured will be pregnancies, abortions, repeat Plan B use, presence of
      gonorrhea or Chlamydia infection at the time of presentation for EC, number of days to first
      bleeding episode and duration of that bleeding episode, further bleeding patterns, frequency
      of unprotected intercourse, use of a barrier method for prevention of sexually transmitted
      infections, patient satisfaction with the chosen method and symptoms possibly related to
      contraception use. Patients selecting the IUD will be assessed for IUD expulsion,
      perforation, and removal.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2008</start_date>
  <completion_date type="Actual">May 2009</completion_date>
  <primary_completion_date type="Actual">April 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Use of an Effective Method of Contraception at 6 Months After Requesting Emergency Contraception</measure>
    <time_frame>6 months</time_frame>
    <description>Use of a method of contraception with a typical efficacy rate &gt;= to 92%. This includes combined hormonal contraception (combined oral contraceptive pills, the contraceptive patch and ring), sterilization, IUDs, Depo-provera, and contraceptive implants.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pregnancy</measure>
    <time_frame>6 months</time_frame>
    <description>positive urine pregnancy test at anytime within 6 months of presenting for emergency contraception.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Infection</measure>
    <time_frame>6 months</time_frame>
    <description>diagnosis and treatment for pelvic inflammatory disease</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IUD Expulsion, Removal, or Perforation</measure>
    <time_frame>6 months</time_frame>
    <description>patient reports IUD expulsion, removal, or perforation OR one of these events was documented at the clinic where patient received care.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">57</enrollment>
  <condition>Pregnancy</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>IUD</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Oral levonorgestrel</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Copper T380 IUD</intervention_name>
    <description>Copper T380 IUD</description>
    <arm_group_label>1</arm_group_label>
    <other_name>Paragard IUD</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>levonorgestrel</intervention_name>
    <description>1.5 mg</description>
    <arm_group_label>2</arm_group_label>
    <other_name>Plan B</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women 18-45 years old, in need of EC (had unprotected intercourse within 120 hours),
             willing to give consent for participation in research, willing to comply with the
             study requirements, and accessible by telephone.

          -  Patients selecting the IUD need to identify themselves as desiring long-term
             contraception.

        Exclusion Criteria:

          -  Current pregnancy,

          -  Had pelvic inflammatory disease or a septic abortion within the past 3 months or
             gonorrheal or chlamydial infection in the last 60 days,

          -  Current behavior suggesting a high risk for pelvic inflammatory disease

          -  Allergy to copper, or Wilson's disease (for patients selecting Paragard) or allergy to
             levonorgestrel (for patients selecting Plan B)

          -  Intracavitary of symptomatic uterine fibroids, and abnormalities of the uterus that
             distort the uterine cavity,

          -  Mucopurulent cervicitis,

          -  A previously placed IUD that has not been removed

          -  Genital bleeding of unknown etiology

          -  Ovarian, cervical or endometrial cancer,

          -  Small uterine cavity
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Turok, MD/MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Utah</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Planned Parenthood Association of Utah, West Valley City Clinic</name>
      <address>
        <city>West Valley City</city>
        <state>Utah</state>
        <zip>84119</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 25, 2008</study_first_submitted>
  <study_first_submitted_qc>April 28, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 30, 2008</study_first_posted>
  <results_first_submitted>June 18, 2009</results_first_submitted>
  <results_first_submitted_qc>August 4, 2009</results_first_submitted_qc>
  <results_first_posted type="Estimate">August 6, 2009</results_first_posted>
  <last_update_submitted>December 4, 2014</last_update_submitted>
  <last_update_submitted_qc>December 4, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 22, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Utah</investigator_affiliation>
    <investigator_full_name>David Turok</investigator_full_name>
    <investigator_title>PI</investigator_title>
  </responsible_party>
  <keyword>contraception</keyword>
  <keyword>emergency contraception</keyword>
  <keyword>pregnancy prevention after unprotected intercourse</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Emergencies</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Levonorgestrel</mesh_term>
    <mesh_term>Copper</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Copper T380 IUD</title>
          <description>IUD</description>
        </group>
        <group group_id="P2">
          <title>Levonorgestrel</title>
          <description>Oral levonorgestrel</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="23"/>
                <participants group_id="P2" count="34"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
                <participants group_id="P2" count="22"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="12"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="12"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Copper T380 IUD</title>
          <description>IUD</description>
        </group>
        <group group_id="B2">
          <title>Levonorgestrel</title>
          <description>Oral levonorgestrel</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="23"/>
            <count group_id="B2" value="34"/>
            <count group_id="B3" value="57"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                    <measurement group_id="B2" value="34"/>
                    <measurement group_id="B3" value="57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24.7" spread="6.7"/>
                    <measurement group_id="B2" value="23.0" spread="4.7"/>
                    <measurement group_id="B3" value="23.7" spread="5.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                    <measurement group_id="B2" value="34"/>
                    <measurement group_id="B3" value="57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                    <measurement group_id="B2" value="34"/>
                    <measurement group_id="B3" value="57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Use of an Effective Method of Contraception at 6 Months After Requesting Emergency Contraception</title>
        <description>Use of a method of contraception with a typical efficacy rate &gt;= to 92%. This includes combined hormonal contraception (combined oral contraceptive pills, the contraceptive patch and ring), sterilization, IUDs, Depo-provera, and contraceptive implants.</description>
        <time_frame>6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Copper T380 IUD</title>
            <description>IUD</description>
          </group>
          <group group_id="O2">
            <title>Levonorgestrel</title>
            <description>Oral levonorgestrel</description>
          </group>
        </group_list>
        <measure>
          <title>Use of an Effective Method of Contraception at 6 Months After Requesting Emergency Contraception</title>
          <description>Use of a method of contraception with a typical efficacy rate &gt;= to 92%. This includes combined hormonal contraception (combined oral contraceptive pills, the contraceptive patch and ring), sterilization, IUDs, Depo-provera, and contraceptive implants.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pregnancy</title>
        <description>positive urine pregnancy test at anytime within 6 months of presenting for emergency contraception.</description>
        <time_frame>6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Copper T380 IUD</title>
            <description>IUD</description>
          </group>
          <group group_id="O2">
            <title>Levonorgestrel</title>
            <description>Oral levonorgestrel</description>
          </group>
        </group_list>
        <measure>
          <title>Pregnancy</title>
          <description>positive urine pregnancy test at anytime within 6 months of presenting for emergency contraception.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Infection</title>
        <description>diagnosis and treatment for pelvic inflammatory disease</description>
        <time_frame>6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Copper T380 IUD</title>
            <description>IUD</description>
          </group>
          <group group_id="O2">
            <title>Levonorgestrel</title>
            <description>Oral levonorgestrel</description>
          </group>
        </group_list>
        <measure>
          <title>Infection</title>
          <description>diagnosis and treatment for pelvic inflammatory disease</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>IUD Expulsion, Removal, or Perforation</title>
        <description>patient reports IUD expulsion, removal, or perforation OR one of these events was documented at the clinic where patient received care.</description>
        <time_frame>6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Copper T380 IUD</title>
            <description>IUD</description>
          </group>
          <group group_id="O2">
            <title>Levonorgestrel</title>
            <description>Oral levonorgestrel</description>
          </group>
        </group_list>
        <measure>
          <title>IUD Expulsion, Removal, or Perforation</title>
          <description>patient reports IUD expulsion, removal, or perforation OR one of these events was documented at the clinic where patient received care.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Copper T380 IUD</title>
          <description>IUD</description>
        </group>
        <group group_id="E2">
          <title>Levonorgestrel</title>
          <description>Oral levonorgestrel</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>4</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>David Turok, MD</name_or_title>
      <organization>University of Utah</organization>
      <phone>801-581-7647</phone>
      <email>david.turok@hsc.utah.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

